Graham Capital Management L.P. lifted its position in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) by 133.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 20,147 shares of the industrial products company's stock after acquiring an additional 11,520 shares during the quarter. Graham Capital Management L.P. owned 0.08% of Proto Labs worth $706,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in PRLB. GAMMA Investing LLC boosted its holdings in Proto Labs by 249.4% in the 1st quarter. GAMMA Investing LLC now owns 926 shares of the industrial products company's stock valued at $32,000 after purchasing an additional 661 shares in the last quarter. CWM LLC boosted its stake in shares of Proto Labs by 50.4% in the first quarter. CWM LLC now owns 1,840 shares of the industrial products company's stock valued at $64,000 after buying an additional 617 shares in the last quarter. PNC Financial Services Group Inc. boosted its stake in shares of Proto Labs by 14.1% in the first quarter. PNC Financial Services Group Inc. now owns 2,165 shares of the industrial products company's stock valued at $76,000 after buying an additional 267 shares in the last quarter. State of Wyoming acquired a new position in Proto Labs during the first quarter worth $99,000. Finally, Lazard Asset Management LLC raised its position in Proto Labs by 182.3% in the fourth quarter. Lazard Asset Management LLC now owns 5,875 shares of the industrial products company's stock worth $228,000 after acquiring an additional 3,794 shares in the last quarter. Institutional investors and hedge funds own 84.54% of the company's stock.
Proto Labs Price Performance
Proto Labs stock traded down $0.53 during trading hours on Wednesday, hitting $49.05. The stock had a trading volume of 119,443 shares, compared to its average volume of 159,873. Proto Labs, Inc. has a 1-year low of $26.34 and a 1-year high of $51.09. The stock has a market capitalization of $1.17 billion, a price-to-earnings ratio of 81.76 and a beta of 1.27. The stock's fifty day moving average is $44.85 and its two-hundred day moving average is $39.88.
Proto Labs (NYSE:PRLB - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The industrial products company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.33 by $0.08. The business had revenue of $135.06 million for the quarter, compared to analyst estimates of $128.05 million. Proto Labs had a net margin of 2.91% and a return on equity of 2.22%. The business's revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.38 EPS. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. As a group, sell-side analysts anticipate that Proto Labs, Inc. will post 0.81 EPS for the current year.
Insider Activity
In other Proto Labs news, CEO Suresh Krishna purchased 1,725 shares of the stock in a transaction dated Monday, August 4th. The shares were acquired at an average cost of $43.51 per share, for a total transaction of $75,054.75. Following the completion of the transaction, the chief executive officer directly owned 18,021 shares of the company's stock, valued at $784,093.71. This trade represents a 10.59% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. 1.70% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on the company. Craig Hallum raised Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 target price for the company in a report on Friday, August 1st. Cantor Fitzgerald raised their price objective on shares of Proto Labs from $50.00 to $51.00 and gave the company an "overweight" rating in a research note on Friday, August 1st. Finally, Wall Street Zen raised shares of Proto Labs from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 2nd. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $52.50.
Read Our Latest Analysis on Proto Labs
About Proto Labs
(
Free Report)
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
Featured Stories

Before you consider Proto Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.
While Proto Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.